Meclofenamate

Generic name: Pronounced as (me kloe fen am' ate)
Brand names
  • Meclodium®
  • Meclomen®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 11/15/2020

[Posted 10/15/2020]

AUDIENCE: Consumer, Patient, Health Professional, Pharmacy

ISSUE: FDA is warning that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding the baby and possible complications.

For prescription NSAIDs, FDA is requiring changes to the prescribing information to describe the risk of kidney problems in unborn babies that result in low amniotic fluid.

For over-the-counter (OTC) NSAIDs intended for use in adults, FDA will also update the Drug Facts labels, available at: http://bit.ly/2Uadlbz. These labels already warn to avoid using NSAIDs during the last 3 months of pregnancy because the medicines may cause problems in the unborn child or complications during delivery. The Drug Facts labels already advise pregnant and breastfeeding women to ask a health care professional before using these medicines.

BACKGROUND:

NSAIDs

  • are a class of medicines available by prescription and OTC. They are some of the most commonly used medicines for pain and fever.

  • are used to treat medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu.

  • work by blocking the production of certain chemicals in the body that cause inflammation.

  • are available alone and combined with other medicines. Examples of NSAIDs include aspirin, ibuprofen, naproxen, diclofenac, and celecoxib.

Common side effects of NSAIDs include: stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.

RECOMMENDATION:

Consumers/Patients

  • If you are pregnant, do not use NSAIDs at 20 weeks or later in pregnancy unless specifically advised to do so by your health care professional because these medicines may cause problems in your unborn baby.

  • Many OTC medicines contain NSAIDs, including those used for pain, colds, flu, and insomnia, so it is important to read the Drug Facts labels, available at: http://bit.ly/2Uadlbz, to find out if the medicines contain NSAIDs.

  • Talk to your health care professional or pharmacist if you have questions or concerns about NSAIDs or which medicines contain them.

  • Other medicines, such as acetaminophen, are available to treat pain and fever during pregnancy. Talk to your pharmacist or health care professional for help deciding which might be best.

Health Care Professionals

  • FDA recommends that health care professionals should limit prescribing NSAIDs between 20 to 30 weeks of pregnancy and avoid prescribing them after 30 weeks of pregnancy. If NSAID treatment is determined necessary, limit use to the lowest effective dose and shortest duration possible. Consider ultrasound monitoring of amniotic fluid if NSAID treatment extends beyond 48 hours and discontinue the NSAID if oligohydramnios is found. FDA is warning that use of NSAIDs around 20 weeks gestation or later in pregnancy may cause fetal renal dysfunction leading to oligohydramnios and, in some cases, neonatal renal impairment.

  • These adverse outcomes are seen, on average, after days to weeks of treatment, although oligohydramnios has been infrequently reported as soon as 48 hours after NSAID initiation.

  • Oligohydramnios is often, but not always, reversible with treatment discontinuation.

  • Complications of prolonged oligohydramnios may include limb contractures and delayed lung maturation. In some postmarketing cases of impaired neonatal renal function, invasive procedures such as exchange transfusion or dialysis were required.

  • If NSAID treatment is deemed necessary between 20 to 30 weeks of pregnancy, limit use to the lowest effective dose and shortest duration possible. As currently described in the NSAID labels, avoid prescribing NSAIDs at 30 weeks and later in pregnancy because of the additional risk of premature closure of the fetal ductus arteriosus.

  • The above recommendations do not apply to low-dose 81 mg aspirin prescribed for certain conditions in pregnancy.

  • Consider ultrasound monitoring of amniotic fluid if NSAID treatment extends beyond 48 hours. Discontinue the NSAID if oligohydramnios occurs and follow up according to clinical practice.

For more information visit the FDA website at: http://www.fda.gov/Safety/MedWatch/SafetyInformation and http://www.fda.gov/Drugs/DrugSafety.

People who take nonsteroidal anti-inflammatory drugs (NSAIDs) (other than aspirin) such as meclofenamate may have a higher risk of having a heart attack or a stroke than people who do not take these medications. These events may happen without warning and may cause death. This risk may be higher for people who take NSAIDs for a long time. Tell your doctor if you or anyone in your family has or has ever had heart disease, a heart attack, or a stroke, if you smoke, and if you have or have ever had high cholesterol, high blood pressure, or diabetes. Get emergency medical help right away if you experience any of the following symptoms: chest pain, shortness of breath, weakness in one part or side of the body, or slurred speech.

If you will be undergoing a coronary artery bypass graft (CABG; a type of heart surgery), you should not take meclofenamate right before or right after the surgery.

NSAIDs such as meclofenamate may cause ulcers, bleeding, or holes in the stomach or intestine. These problems may develop at any time during treatment, may happen without warning symptoms, and may cause death. The risk may be higher for people who take NSAIDs for a long time, are older in age, have poor health, or drink large amounts of alcohol while taking meclofenamate. Tell your doctor if you take any of the following medications: anticoagulants ('blood thinners') such as warfarin (Coumadin); aspirin; other NSAIDs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn); or oral steroids such as dexamethasone (Decadron, Dexone), methylprednisolone (Medrol), and prednisone (Deltasone). Also tell your doctor if you have or have ever had ulcers, bleeding in your stomach or intestines, or other bleeding disorders. If you experience any of the following symptoms, stop taking meclofenamate and call your doctor: stomach pain, heartburn, vomit that is bloody or looks like coffee grounds, blood in the stool, or black and tarry stools.

Keep all appointments with your doctor and the laboratory. Your doctor will monitor your symptoms carefully and will probably order certain tests to check your body's response to meclofenamate. Be sure to tell your doctor how you are feeling so that your doctor can prescribe the right amount of medication to treat your condition with the lowest risk of serious side effects.

Your doctor or pharmacist will give you the manufacturer's patient information sheet (Medication Guide) when you begin treatment with meclofenamate and each time you refill your prescription. Read the information carefully and ask your doctor or pharmacist if you have any questions. You can also visit the Food and Drug Administration (FDA) website (http://www.fda.gov/Drugs) to obtain the Medication Guide.

Meclofenamate is used to relieve pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints). It is also used to relieve other types of mild to moderate pain, including menstrual pain (pain that happens before or during a menstrual period). It also may be used to decrease bleeding in women who have abnormally heavy menstrual blood loss. Meclofenamate is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain, fever, and inflammation.

Meclofenamate comes as a capsule to take by mouth. It is usually taken three or four times a day for arthritis, three times a day for heavy menstrual blood loss, or every 4 to 6 hours as needed for pain. Meclofenamate may be taken with food or milk to prevent nausea. If you take meclofenamate regularly, take it at the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take meclofenamate exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

If you are taking meclofenamate to reduce heavy menstrual bleeding, your bleeding should decrease during your treatment. Call your doctor if your bleeding does not decrease or if you experience spotting or bleeding between menstrual periods.

If you are taking meclofenamate to relieve the symptoms of arthritis, your symptoms may begin to improve within a few days. It may take 2 to 3 weeks or longer for you to feel the full benefit of meclofenamate.

Meclofenamate is also used to treat ankylosing spondylitis (arthritis that mainly affects the spine), gouty arthritis (joint pain caused by a build-up of certain substances in the joints), and psoriatic arthritis (arthritis that occurs with a long-lasting skin disease that causes scaling and swelling). Talk to your doctor about the risks of using this medication to treat your condition.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking meclofenamate,

  • tell your doctor and pharmacist if you are allergic to meclofenamate, aspirin, or other NSAIDs such as ibuprofen (Advil, Motrin) and naproxen (Aleve, Naprosyn), any other medications, or any of the inactive ingredients in meclofenamate capsules. Ask your pharmacist for a list of the inactive ingredients.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention the medications listed in the IMPORTANT WARNING section and any of the following: angiotensin-converting enzyme (ACE) inhibitors such as benazepril (Lotensin), captopril (Capoten), enalapril (Vasotec), fosinopril (Monopril), lisinopril (Prinivil, Zestril), moexipril (Univasc), perindopril (Aceon), quinapril (Accupril), ramipril (Altace), and trandolapril (Mavik); diuretics ('water pills'); lithium (Eskalith, Lithobid); and methotrexate (Rheumatrex). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had any of the conditions mentioned in the IMPORTANT WARNING section or asthma, especially if you also have frequent stuffed or runny nose or nasal polyps (swelling of the lining of the nose); swelling of the hands, feet, ankles, or lower legs; or liver or kidney disease.

  • tell your doctor if you are pregnant, especially if you are in the last few months of your pregnancy, you plan to become pregnant, or you are breast-feeding. If you become pregnant while taking meclofenamate, call your doctor.

  • talk to your doctor about the risks and benefits of taking meclofenamate if you are 75 years of age or older. Do not take this medication for a longer period of time or at a higher dose than recommended by your doctor.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking meclofenamate.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Meclofenamate may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • diarrhea

    • constipation

    • gas

    • sores in the mouth

    • headache

    • ringing in the ears

  • Some side effects can be serious. If you experience any of the following symptoms, or those mentioned in the IMPORTANT WARNING section, call your doctor immediately. Do not take any more meclofenamate until you speak to your doctor.

    • blurred vision

    • unexplained weight gain

    • fever

    • blisters

    • rash

    • itching

    • hives

    • swelling of the eyes, face, lips, tongue, throat, arms, hands, feet, ankles, or lower legs

    • hoarseness

    • difficulty breathing or swallowing

    • yellowing of the skin or eyes

    • excessive tiredness

    • unusual bleeding or bruising

    • lack of energy

    • nausea

    • loss of appetite

    • pain in the upper right part of the stomach

    • flu-like symptoms

    • pale skin

    • fast heartbeat

    • cloudy, discolored, or bloody urine

    • back pain

    • difficult or painful urination

  • Meclofenamate may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdoses may include:

  • behavior that does not make sense

  • agitation

  • seizures

  • decreased urination

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Moxifloxacin Moxifloxacin Meclofenamic acid may increase the neuroexcitatory activities of Moxifloxacin.
Alendronate Alendronate The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Alendronic acid.
Anagrelide Anagrelide The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Anagrelide.
Candesartan Candesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Candesartan is combined with Meclofenamic acid.
Cilostazol Cilostazol The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Cilostazol.
Clopidogrel Clopidogrel The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Clopidogrel.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) The therapeutic efficacy of Conjugated estrogens can be decreased when used in combination with Meclofenamic acid.
Fenofibrate Fenofibrate Meclofenamic acid may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine The therapeutic efficacy of Guanfacine can be decreased when used in combination with Meclofenamic acid.
Magnesium Hydroxide Magnesium Hydroxide Meclofenamic acid may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Methylergonovine Methylergonovine The risk or severity of hypertension can be increased when Methylergometrine is combined with Meclofenamic acid.
Mycophenolate Mycophenolate Meclofenamic acid may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Naratriptan.
Olsalazine Olsalazine The therapeutic efficacy of Olsalazine can be decreased when used in combination with Meclofenamic acid.
Penbutolol Penbutolol Meclofenamic acid may decrease the antihypertensive activities of Acebutolol.
Potassium Potassium Meclofenamic acid may decrease the excretion rate of Potassium cation which could result in a higher serum level.
Prednisone Prednisone The risk or severity of gastrointestinal irritation can be increased when Meclofenamic acid is combined with Prednisone.
Ranitidine Ranitidine Meclofenamic acid may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine The therapeutic efficacy of Reserpine can be decreased when used in combination with Meclofenamic acid.
Rizatriptan Rizatriptan Meclofenamic acid may decrease the excretion rate of Rizatriptan which could result in a higher serum level.
Sumatriptan Sumatriptan Meclofenamic acid may decrease the excretion rate of Sumatriptan which could result in a higher serum level.
Tacrolimus Tacrolimus The risk or severity of renal failure can be increased when Meclofenamic acid is combined with Tacrolimus.
Tiludronate Tiludronate The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Etidronic acid.
Triamcinolone Triamcinolone The risk or severity of gastrointestinal irritation can be increased when Triamcinolone is combined with Meclofenamic acid.
Zolmitriptan Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Meclofenamic acid.
Ampicillin Injection Ampicillin Injection Meclofenamic acid may decrease the excretion rate of Ampicillin which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Meclofenamic acid may decrease the excretion rate of Doxycycline which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection Meclofenamic acid may decrease the excretion rate of Fluconazole which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection The risk or severity of nephrotoxicity can be increased when Meclofenamic acid is combined with Foscarnet.
Hydromorphone Injection Hydromorphone Injection Meclofenamic acid may decrease the excretion rate of Hydromorphone which could result in a higher serum level.
Levofloxacin Injection Levofloxacin Injection Meclofenamic acid may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection Meclofenamic acid may decrease the excretion rate of Meperidine which could result in a higher serum level.
Methylprednisolone Injection Methylprednisolone Injection The risk or severity of gastrointestinal irritation can be increased when Methylprednisolone is combined with Meclofenamic acid.
Metoclopramide Injection Metoclopramide Injection Meclofenamic acid may decrease the excretion rate of Metoclopramide which could result in a higher serum level.
Pamidronate Injection Pamidronate Injection The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Pamidronic acid.
Vancomycin Injection Vancomycin Injection Meclofenamic acid may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Zidovudine Injection Zidovudine Injection The risk or severity of bleeding can be increased when Zidovudine is combined with Meclofenamic acid.
Altretamine Altretamine Meclofenamic acid may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Cyclosporine Cyclosporine The risk or severity of renal failure and hypertension can be increased when Meclofenamic acid is combined with Cyclosporine.
Enoxaparin Injection Enoxaparin Injection The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Enoxaparin.
Torsemide Torsemide The therapeutic efficacy of Torasemide can be decreased when used in combination with Meclofenamic acid.
Eprosartan Eprosartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Eprosartan is combined with Meclofenamic acid.
Meloxicam Meloxicam The risk or severity of adverse effects can be increased when Meloxicam is combined with Meclofenamic acid.
Pantoprazole Pantoprazole Meclofenamic acid may decrease the excretion rate of Pantoprazole which could result in a higher serum level.
Risedronate Risedronate The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Risedronic acid.
Sevelamer Sevelamer Sevelamer can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Telmisartan Telmisartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Telmisartan is combined with Meclofenamic acid.
Temozolomide Temozolomide Meclofenamic acid may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Meclofenamic acid may decrease the excretion rate of Zaleplon which could result in a higher serum level.
Linezolid Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Meclofenamic acid.
Pentosan Polysulfate Pentosan Polysulfate The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Pentosan polysulfate.
Trimipramine Trimipramine The risk or severity of hypertension can be increased when Trimipramine is combined with Meclofenamic acid.
Perindopril Perindopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Perindopril.
Tenofovir Tenofovir Meclofenamic acid may increase the nephrotoxic activities of Tenofovir.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Choline magnesium trisalicylate.
Dutasteride Dutasteride The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Dutasteride.
Epinephrine Injection Epinephrine Injection The risk or severity of hypertension can be increased when Epinephrine is combined with Meclofenamic acid.
Eplerenone Eplerenone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Eplerenone.
Escitalopram Escitalopram The risk or severity of gastrointestinal bleeding can be increased when Escitalopram is combined with Meclofenamic acid.
Olmesartan Olmesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Olmesartan is combined with Meclofenamic acid.
Zonisamide Zonisamide Meclofenamic acid may decrease the excretion rate of Zonisamide which could result in a higher serum level.
Aripiprazole Aripiprazole The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Aripiprazole.
Atomoxetine Atomoxetine Meclofenamic acid may decrease the excretion rate of Atomoxetine which could result in a higher serum level.
Dexmethylphenidate Dexmethylphenidate The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Dexmethylphenidate.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Almotriptan Almotriptan Meclofenamic acid may decrease the excretion rate of Almotriptan which could result in a higher serum level.
Eletriptan Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Meclofenamic acid.
Emtricitabine Emtricitabine Meclofenamic acid may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine Meclofenamic acid may decrease the excretion rate of Memantine which could result in a higher serum level.
Tadalafil Tadalafil Meclofenamic acid may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Frovatriptan.
Gemifloxacin Gemifloxacin Meclofenamic acid may increase the neuroexcitatory activities of Gemifloxacin.
Oxandrolone Oxandrolone The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Oxandrolone.
Protriptyline Protriptyline The risk or severity of hypertension can be increased when Protriptyline is combined with Meclofenamic acid.
Duloxetine Duloxetine The risk or severity of gastrointestinal bleeding can be increased when Duloxetine is combined with Meclofenamic acid.
Tinidazole Tinidazole Meclofenamic acid may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Bosentan Bosentan The therapeutic efficacy of Bosentan can be decreased when used in combination with Meclofenamic acid.
Cefditoren Cefditoren Meclofenamic acid may decrease the excretion rate of Cefdinir which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Meclofenamic acid may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.
Eszopiclone Eszopiclone Meclofenamic acid may decrease the excretion rate of Eszopiclone which could result in a higher serum level.
Ganciclovir Ganciclovir Meclofenamic acid may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Meclofenamic acid may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Solifenacin.
Valganciclovir Valganciclovir Meclofenamic acid may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Zoledronic Acid Injection Zoledronic Acid Injection The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Zoledronic acid.
Adefovir Adefovir Adefovir may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Meclofenamic acid may decrease the excretion rate of Amphetamine which could result in a higher serum level.
Ibandronate Ibandronate The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Ibandronate.
Isocarboxazid Isocarboxazid The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Isocarboxazid.
Ramelteon Ramelteon Meclofenamic acid may decrease the excretion rate of Ramelteon which could result in a higher serum level.
Fentanyl Fentanyl Fentanyl may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Pregabalin Pregabalin Meclofenamic acid may decrease the excretion rate of Pregabalin which could result in a higher serum level.
Deferasirox Deferasirox The risk or severity of gastrointestinal bleeding and peptic ulcer can be increased when Meclofenamic acid is combined with Deferasirox.
Phenylephrine Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Meclofenamic acid.
Ranolazine Ranolazine Meclofenamic acid may decrease the excretion rate of Ranolazine which could result in a higher serum level.
Rasagiline Rasagiline Meclofenamic acid may decrease the excretion rate of Rasagiline which could result in a higher serum level.
Sitagliptin Sitagliptin Meclofenamic acid may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Meclofenamic acid may decrease the excretion rate of Varenicline which could result in a higher serum level.
Albuterol Albuterol Meclofenamic acid may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Meclofenamic acid may decrease the excretion rate of Paliperidone which could result in a higher serum level.
Clofarabine Injection Clofarabine Injection Meclofenamic acid may decrease the excretion rate of Clofarabine which could result in a higher serum level.
Lubiprostone Lubiprostone Meclofenamic acid may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Aliskiren Aliskiren The risk or severity of renal failure and hypertension can be increased when Meclofenamic acid is combined with Aliskiren.
Bismuth Subsalicylate Bismuth Subsalicylate The therapeutic efficacy of Bismuth subsalicylate can be decreased when used in combination with Meclofenamic acid.
Pemetrexed Injection Pemetrexed Injection Meclofenamic acid may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Lisdexamfetamine Lisdexamfetamine The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Lisdexamfetamine.
Sorafenib Sorafenib Meclofenamic acid may decrease the excretion rate of Sorafenib which could result in a higher serum level.
Levocetirizine Levocetirizine Meclofenamic acid may decrease the excretion rate of Levocetirizine which could result in a higher serum level.
Pegaptanib Injection Pegaptanib Injection Meclofenamic acid may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Azacitidine Injection Azacitidine Injection Meclofenamic acid may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Lenalidomide Lenalidomide Meclofenamic acid may decrease the excretion rate of Lenalidomide which could result in a higher serum level.
Budesonide Budesonide The risk or severity of gastrointestinal irritation can be increased when Meclofenamic acid is combined with Budesonide.
Desmopressin Desmopressin The risk or severity of hypertension, hyponatremia, and water intoxication can be increased when Meclofenamic acid is combined with Desmopressin.
Doripenem Injection Doripenem Injection Meclofenamic acid may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Meclofenamic acid may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine The risk or severity of gastrointestinal bleeding can be increased when Desvenlafaxine is combined with Meclofenamic acid.
Cevimeline Cevimeline Meclofenamic acid may decrease the excretion rate of Cevimeline which could result in a higher serum level.
Nebivolol Nebivolol Meclofenamic acid may decrease the antihypertensive activities of Nebivolol.
Certolizumab Injection Certolizumab Injection Meclofenamic acid may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Meclofenamic acid may decrease the excretion rate of Daptomycin which could result in a higher serum level.
Mitotane Mitotane The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Mitotane.
Methylnaltrexone Injection Methylnaltrexone Injection Meclofenamic acid may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Midazolam Midazolam Meclofenamic acid may decrease the excretion rate of Midazolam which could result in a higher serum level.
Dexrazoxane Injection Dexrazoxane Injection Meclofenamic acid may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.
Milnacipran Milnacipran The risk or severity of gastrointestinal bleeding can be increased when Milnacipran is combined with Meclofenamic acid.
Plerixafor Injection Plerixafor Injection Meclofenamic acid may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The risk or severity of renal failure can be increased when Sodium phosphate, monobasic is combined with Meclofenamic acid.
Fesoterodine Fesoterodine Meclofenamic acid may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Betaxolol Betaxolol Meclofenamic acid may decrease the antihypertensive activities of Betaxolol.
Iloperidone Iloperidone The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Iloperidone.
Prasugrel Prasugrel The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Prasugrel.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Meclofenamic acid may increase the excretion rate of Tolvaptan which could result in a lower serum level and potentially a reduction in efficacy.
Dronedarone Dronedarone The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection Meclofenamic acid may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Meclofenamic acid may decrease the excretion rate of Palonosetron which could result in a higher serum level.
Saxagliptin Saxagliptin Meclofenamic acid may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Meclofenamic acid may decrease the excretion rate of Telavancin which could result in a higher serum level.
Topotecan Topotecan Meclofenamic acid may decrease the excretion rate of Topotecan which could result in a higher serum level.
Asenapine Asenapine The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Asenapine.
Dabigatran Dabigatran The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Dabigatran.
Dalfampridine Dalfampridine Meclofenamic acid may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Lurasidone Lurasidone The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Lurasidone.
Acetaminophen Injection Acetaminophen Injection The risk or severity of adverse effects can be increased when Acetaminophen is combined with Meclofenamic acid.
Vilazodone Vilazodone The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Vilazodone.
Ipilimumab Injection Ipilimumab Injection Meclofenamic acid may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Meclofenamic acid may decrease the excretion rate of Aldesleukin which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection Meclofenamic acid may decrease the excretion rate of Terbutaline which could result in a higher serum level.
Azilsartan Azilsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Azilsartan medoxomil is combined with Meclofenamic acid.
Roflumilast Roflumilast Meclofenamic acid may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Potassium Iodide Potassium Iodide Potassium Iodide may increase the hyperkalemic activities of Meclofenamic acid.
Rivaroxaban Rivaroxaban The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Rivaroxaban.
Ticagrelor Ticagrelor The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Ticagrelor.
Ruxolitinib Ruxolitinib Meclofenamic acid may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam Meclofenamic acid may decrease the excretion rate of Clobazam which could result in a higher serum level.
Deferiprone Deferiprone Meclofenamic acid may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Cabergoline Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Meclofenamic acid.
Naloxone Injection Naloxone Injection Meclofenamic acid may decrease the excretion rate of Naloxone which could result in a higher serum level.
Ambrisentan Ambrisentan The therapeutic efficacy of Ambrisentan can be decreased when used in combination with Meclofenamic acid.
Fondaparinux Injection Fondaparinux Injection The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Fondaparinux.
Iloprost Iloprost The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Iloprost.
Enzalutamide Enzalutamide Meclofenamic acid may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Asparaginase Erwinia Chrysanthemi Injection Asparaginase Erwinia Chrysanthemi Injection The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Asparaginase Erwinia chrysanthemi.
Mirabegron Mirabegron Meclofenamic acid may decrease the excretion rate of Mirabegron which could result in a higher serum level.
Corticotropin, Repository Injection Corticotropin, Repository Injection The risk or severity of gastrointestinal irritation can be increased when Corticotropin is combined with Meclofenamic acid.
Teduglutide Injection Teduglutide Injection Meclofenamic acid may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Icosapent Ethyl Icosapent Ethyl The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Icosapent ethyl.
Alogliptin Alogliptin Meclofenamic acid may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide Meclofenamic acid may decrease the excretion rate of Pomalidomide which could result in a higher serum level.
Apixaban Apixaban The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Apixaban.
Canagliflozin Canagliflozin Meclofenamic acid may decrease the excretion rate of Canagliflozin which could result in a higher serum level.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Trametinib Trametinib Meclofenamic acid may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran The risk or severity of gastrointestinal bleeding can be increased when Levomilnacipran is combined with Meclofenamic acid.
Ertapenem Injection Ertapenem Injection Meclofenamic acid may decrease the excretion rate of Ertapenem which could result in a higher serum level.
Vortioxetine Vortioxetine Meclofenamic acid may decrease the excretion rate of Vortioxetine which could result in a higher serum level.
Ketorolac Injection Ketorolac Injection The risk or severity of adverse effects can be increased when Ketorolac is combined with Meclofenamic acid.
Sofosbuvir Sofosbuvir Meclofenamic acid may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast Meclofenamic acid may decrease the excretion rate of Apremilast which could result in a higher serum level.
Droxidopa Droxidopa Meclofenamic acid may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Testosterone Injection Testosterone Injection The therapeutic efficacy of Testosterone can be increased when used in combination with Meclofenamic acid.
Vorapaxar Vorapaxar The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Vorapaxar.
Edoxaban Edoxaban The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Edoxaban.
Methamphetamine Methamphetamine Meclofenamic acid may decrease the excretion rate of Metamfetamine which could result in a higher serum level.
Tasimelteon Tasimelteon Meclofenamic acid may decrease the excretion rate of Tasimelteon which could result in a higher serum level.
Riociguat Riociguat The therapeutic efficacy of Riociguat can be decreased when used in combination with Meclofenamic acid.
Risperidone Injection Risperidone Injection The risk or severity of hypertension can be increased when Risperidone is combined with Meclofenamic acid.
Haloperidol Injection Haloperidol Injection The therapeutic efficacy of Haloperidol can be increased when used in combination with Meclofenamic acid.
Amiloride Amiloride The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Amiloride.
Macitentan Macitentan The therapeutic efficacy of Macitentan can be decreased when used in combination with Meclofenamic acid.
Flibanserin Flibanserin The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Flibanserin.
Prednisolone Prednisolone The risk or severity of gastrointestinal irritation can be increased when Prednisolone is combined with Meclofenamic acid.
Brexpiprazole Brexpiprazole The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Brexpiprazole.
Ziprasidone Injection Ziprasidone Injection The risk or severity of hypertension can be increased when Ziprasidone is combined with Meclofenamic acid.
Cariprazine Cariprazine The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Cariprazine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Meclofenamic acid may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Ixazomib Ixazomib Meclofenamic acid may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Meclofenamic acid may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Dexamethasone Injection Dexamethasone Injection The risk or severity of gastrointestinal irritation can be increased when Dexamethasone is combined with Meclofenamic acid.
Defibrotide Injection Defibrotide Injection The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Defibrotide.
Brivaracetam Injection Brivaracetam Injection Meclofenamic acid may decrease the excretion rate of Brivaracetam which could result in a higher serum level.
Midodrine Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Meclofenamic acid.
Selexipag Selexipag The therapeutic efficacy of Selexipag can be decreased when used in combination with Meclofenamic acid.
Furosemide Injection Furosemide Injection The therapeutic efficacy of Furosemide can be decreased when used in combination with Meclofenamic acid.
Lixisenatide Injection Lixisenatide Injection Meclofenamic acid may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Meclofenamic acid may decrease the excretion rate of Doxepin which could result in a higher serum level.
Deutetrabenazine Deutetrabenazine Meclofenamic acid may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Meclofenamic acid may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Deflazacort Deflazacort The risk or severity of gastrointestinal irritation can be increased when Deflazacort is combined with Meclofenamic acid.
Safinamide Safinamide The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Safinamide.
Edaravone Injection Edaravone Injection The excretion of Edaravone can be decreased when combined with Meclofenamic acid.
Naldemedine Naldemedine Meclofenamic acid may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Benznidazole Benznidazole Meclofenamic acid may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Meclofenamic acid may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Betrixaban Betrixaban The risk or severity of bleeding can be increased when Betrixaban is combined with Meclofenamic acid.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Apalutamide Apalutamide Meclofenamic acid may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Baricitinib Baricitinib Meclofenamic acid may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine The therapeutic efficacy of Lofexidine can be decreased when used in combination with Meclofenamic acid.
Plazomicin Injection Plazomicin Injection Meclofenamic acid may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Cannabidiol Cannabidiol The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Cannabidiol.
Stiripentol Stiripentol Meclofenamic acid may decrease the excretion rate of Stiripentol which could result in a higher serum level.
Prucalopride Prucalopride Meclofenamic acid may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Siponimod Siponimod The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Siponimod.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Caplacizumab.
Solriamfetol Solriamfetol The risk or severity of hypertension can be increased when Solriamfetol is combined with Meclofenamic acid.
Pitolisant Pitolisant The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Pitolisant.
Phenytoin Injection Phenytoin Injection The serum concentration of Phenytoin can be increased when it is combined with Meclofenamic acid.
Fosphenytoin Injection Fosphenytoin Injection The therapeutic efficacy of Fosphenytoin can be increased when used in combination with Meclofenamic acid.
Selpercatinib Selpercatinib The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Selpercatinib.
Naxitamab-gqgk Injection Naxitamab-gqgk Injection The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Naxitamab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Drospirenone.
Viloxazine Viloxazine Meclofenamic acid may decrease the excretion rate of Viloxazine which could result in a higher serum level.
Tobramycin Injection Tobramycin Injection Meclofenamic acid may decrease the excretion rate of Tobramycin which could result in a higher serum level.
Fenoprofen Fenoprofen The risk or severity of adverse effects can be increased when Fenoprofen is combined with Meclofenamic acid.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Meclofenamic acid.
Mefenamic Acid Mefenamic Acid The risk or severity of adverse effects can be increased when Mefenamic acid is combined with Meclofenamic acid.
Naproxen Naproxen The risk or severity of adverse effects can be increased when Naproxen is combined with Meclofenamic acid.
Tolmetin Tolmetin The risk or severity of adverse effects can be increased when Tolmetin is combined with Meclofenamic acid.
Sulindac Sulindac The risk or severity of adverse effects can be increased when Sulindac is combined with Meclofenamic acid.
Trazodone Trazodone The risk or severity of gastrointestinal bleeding can be increased when Trazodone is combined with Meclofenamic acid.
Isotretinoin Isotretinoin Meclofenamic acid may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Meclofenamic acid may decrease the excretion rate of Sucralfate which could result in a higher serum level.
Floxuridine Floxuridine The therapeutic efficacy of Floxuridine can be decreased when used in combination with Meclofenamic acid.
Metaxalone Metaxalone Meclofenamic acid may decrease the excretion rate of Metaxalone which could result in a higher serum level.
Methotrexate Injection Methotrexate Injection The serum concentration of Methotrexate can be increased when it is combined with Meclofenamic acid.
Methsuximide Methsuximide The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Methsuximide.
Diethylpropion Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Meclofenamic acid.
Chlorpromazine Chlorpromazine Meclofenamic acid may decrease the excretion rate of Chlorpromazine which could result in a higher serum level.
Diazepam Diazepam Meclofenamic acid may decrease the excretion rate of Diazepam which could result in a higher serum level.
Oxazepam Oxazepam Meclofenamic acid may decrease the excretion rate of Oxazepam which could result in a higher serum level.
Flurazepam Flurazepam Meclofenamic acid may decrease the excretion rate of Flurazepam which could result in a higher serum level.
Clorazepate Clorazepate Meclofenamic acid may decrease the excretion rate of Clorazepic acid which could result in a higher serum level.
Lorazepam Lorazepam Meclofenamic acid may decrease the excretion rate of Lorazepam which could result in a higher serum level.
Phenoxybenzamine Phenoxybenzamine The therapeutic efficacy of Phenoxybenzamine can be decreased when used in combination with Meclofenamic acid.
Carmustine Carmustine Meclofenamic acid may decrease the excretion rate of Carmustine which could result in a higher serum level.
Amantadine Amantadine Meclofenamic acid may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine Meclofenamic acid may decrease the excretion rate of Codeine which could result in a higher serum level.
Bromocriptine Bromocriptine The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Bromocriptine.
Metaproterenol Metaproterenol The risk or severity of hypertension can be increased when Orciprenaline is combined with Meclofenamic acid.
Tranylcypromine Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Meclofenamic acid.
Phenelzine Phenelzine Meclofenamic acid may decrease the excretion rate of Phenelzine which could result in a higher serum level.
Ergoloid Mesylates Ergoloid Mesylates The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Ergoloid mesylate.
Tetracycline Tetracycline Meclofenamic acid may decrease the excretion rate of Tetracycline which could result in a higher serum level.
Thioridazine Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Meclofenamic acid.
Trifluoperazine Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Meclofenamic acid.
Bleomycin Bleomycin Meclofenamic acid may decrease the excretion rate of Bleomycin which could result in a higher serum level.
Sulfadiazine Sulfadiazine Meclofenamic acid may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.
Methadone Methadone The therapeutic efficacy of Methadone can be decreased when used in combination with Meclofenamic acid.
Benztropine Benztropine Meclofenamic acid may decrease the excretion rate of Benzatropine which could result in a higher serum level.
Colestipol Colestipol Colestipol can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Maprotiline Maprotiline Meclofenamic acid may decrease the excretion rate of Maprotiline which could result in a higher serum level.
Ibuprofen Ibuprofen The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ibuprofen.
Azathioprine Azathioprine Meclofenamic acid may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Phentermine Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Meclofenamic acid.
Methylphenidate Methylphenidate Meclofenamic acid may decrease the excretion rate of Methylphenidate which could result in a higher serum level.
Amoxapine Amoxapine The risk or severity of hypertension can be increased when Amoxapine is combined with Meclofenamic acid.
Sulfasalazine Sulfasalazine The therapeutic efficacy of Sulfasalazine can be decreased when used in combination with Meclofenamic acid.
Hydrocortisone Hydrocortisone The risk or severity of gastrointestinal irritation can be increased when Hydrocortisone is combined with Meclofenamic acid.
Phenazopyridine Phenazopyridine The risk or severity of nephrotoxicity can be increased when Meclofenamic acid is combined with Phenazopyridine.
Carbamazepine Carbamazepine Meclofenamic acid may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Methyldopa Methyldopa The therapeutic efficacy of Methyldopa can be decreased when used in combination with Meclofenamic acid.
Clonidine Clonidine The therapeutic efficacy of Clonidine can be decreased when used in combination with Meclofenamic acid.
Prazosin Prazosin The therapeutic efficacy of Prazosin can be decreased when used in combination with Meclofenamic acid.
Hydralazine Hydralazine Meclofenamic acid may decrease the antihypertensive activities of Hydralazine.
Cimetidine Cimetidine Meclofenamic acid may decrease the excretion rate of Cimetidine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Meclofenamic acid may decrease the excretion rate of Gentamicin which could result in a higher serum level.
Warfarin Warfarin The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Warfarin.
Clonazepam Clonazepam Meclofenamic acid may decrease the excretion rate of Clonazepam which could result in a higher serum level.
Loperamide Loperamide The risk or severity of hyperkalemia can be increased when Loperamide is combined with Meclofenamic acid.
Promethazine Promethazine Meclofenamic acid may decrease the excretion rate of Promethazine which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Meclofenamic acid may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.
Digoxin Digoxin Meclofenamic acid may decrease the excretion rate of Digoxin which could result in a higher serum level.
Chloroquine Chloroquine Meclofenamic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.
Ethosuximide Ethosuximide The risk or severity of hyperkalemia can be increased when Ethosuximide is combined with Meclofenamic acid.
Triamterene Triamterene The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Triamterene.
Sulfinpyrazone Sulfinpyrazone The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Sulfinpyrazone.
Chlorothiazide Chlorothiazide The therapeutic efficacy of Chlorothiazide can be decreased when used in combination with Meclofenamic acid.
Chlorthalidone Chlorthalidone The therapeutic efficacy of Chlorthalidone can be decreased when used in combination with Meclofenamic acid.
Metolazone Metolazone The therapeutic efficacy of Metolazone can be decreased when used in combination with Meclofenamic acid.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Meclofenamic acid may decrease the excretion rate of Secobarbital which could result in a higher serum level.
Desipramine Desipramine Meclofenamic acid may decrease the excretion rate of Desipramine which could result in a higher serum level.
Amitriptyline Amitriptyline Amitriptyline may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Imipramine Imipramine Imipramine may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Probenecid Probenecid Probenecid may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Quinidine Quinidine Meclofenamic acid may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Meclofenamic acid may decrease the excretion rate of Procainamide which could result in a higher serum level.
Isoniazid Isoniazid Meclofenamic acid may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Meclofenamic acid may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.
Disopyramide Disopyramide Meclofenamic acid may decrease the excretion rate of Disopyramide which could result in a higher serum level.
Valproic Acid Valproic Acid The protein binding of Valproic acid can be decreased when combined with Meclofenamic acid.
Tamoxifen Tamoxifen The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Tamoxifen.
Butabarbital Butabarbital Meclofenamic acid may decrease the excretion rate of Butabarbital which could result in a higher serum level.
Levothyroxine Levothyroxine The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Levothyroxine.
Liothyronine Liothyronine Meclofenamic acid may decrease the excretion rate of Liothyronine which could result in a higher serum level.
Methimazole Methimazole Meclofenamic acid may decrease the excretion rate of Methimazole which could result in a higher serum level.
Chlorpropamide Chlorpropamide The protein binding of Chlorpropamide can be decreased when combined with Meclofenamic acid.
Tolbutamide Tolbutamide The protein binding of Tolbutamide can be decreased when combined with Meclofenamic acid.
Tolazamide Tolazamide The protein binding of Tolazamide can be decreased when combined with Meclofenamic acid.
Dinoprostone Dinoprostone The excretion of Dinoprostone can be decreased when combined with Meclofenamic acid.
Niacin Niacin The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Niacin.
Baclofen Baclofen Meclofenamic acid may decrease the excretion rate of Baclofen which could result in a higher serum level.
Ethambutol Ethambutol Meclofenamic acid may decrease the excretion rate of Ethambutol which could result in a higher serum level.
Methyclothiazide Methyclothiazide The therapeutic efficacy of Methyclothiazide can be decreased when used in combination with Meclofenamic acid.
Hydrochlorothiazide Hydrochlorothiazide The therapeutic efficacy of Hydrochlorothiazide can be decreased when used in combination with Meclofenamic acid.
Dantrolene Dantrolene The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Dantrolene.
Chlorzoxazone Chlorzoxazone Meclofenamic acid may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.
Pyridoxine Pyridoxine Meclofenamic acid may decrease the excretion rate of Pyridoxine which could result in a higher serum level.
Folic Acid Folic Acid Meclofenamic acid may decrease the excretion rate of Folic acid which could result in a higher serum level.
Danazol Danazol The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Danazol.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Meclofenamic acid may decrease the antihypertensive activities of Propranolol.
Minoxidil Minoxidil The therapeutic efficacy of Minoxidil can be decreased when used in combination with Meclofenamic acid.
Pseudoephedrine Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Meclofenamic acid.
Nortriptyline Nortriptyline The risk or severity of hypertension can be increased when Nortriptyline is combined with Meclofenamic acid.
Spironolactone Spironolactone The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Spironolactone.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Phytonadione Phytonadione Meclofenamic acid may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Meclofenamic acid may decrease the excretion rate of Amikacin which could result in a higher serum level.
Nadolol Nadolol Meclofenamic acid may decrease the antihypertensive activities of Nadolol.
Cholestyramine Resin Cholestyramine Resin Cholestyramine can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Allopurinol Allopurinol Meclofenamic acid may decrease the excretion rate of Allopurinol which could result in a higher serum level.
Flavoxate Flavoxate Meclofenamic acid may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Fluorouracil Injection Fluorouracil Injection The therapeutic efficacy of Meclofenamic acid can be decreased when used in combination with Fluorouracil.
Colchicine Colchicine Meclofenamic acid may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Cefadroxil Cefadroxil Meclofenamic acid may decrease the excretion rate of Cefadroxil which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Dacarbazine Dacarbazine Meclofenamic acid may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the excretion rate of Meclofenamic acid which could result in a lower serum level and potentially a reduction in efficacy.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Meclofenamic acid may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.
Ketoconazole Ketoconazole The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Ketoconazole.
Pyrantel Pyrantel Meclofenamic acid may decrease the excretion rate of Pyrantel which could result in a higher serum level.
Captopril Captopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Captopril.
Dipyridamole Dipyridamole The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Dipyridamole.
Isoxsuprine Isoxsuprine The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid The therapeutic efficacy of Etacrynic acid can be decreased when used in combination with Meclofenamic acid.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Metoprolol Metoprolol Meclofenamic acid may decrease the antihypertensive activities of Metoprolol.
Aspirin Aspirin The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Meclofenamic acid.
Salsalate Salsalate The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Salsalate.
Alprazolam Alprazolam Meclofenamic acid may decrease the excretion rate of Alprazolam which could result in a higher serum level.
Temazepam Temazepam Meclofenamic acid may decrease the excretion rate of Temazepam which could result in a higher serum level.
Triazolam Triazolam Meclofenamic acid may decrease the excretion rate of Triazolam which could result in a higher serum level.
Dicyclomine Dicyclomine Meclofenamic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propantheline Propantheline Meclofenamic acid may decrease the excretion rate of Propantheline which could result in a higher serum level.
Trimethoprim Trimethoprim Meclofenamic acid may decrease the excretion rate of Trimethoprim which could result in a higher serum level.
Diltiazem Diltiazem The therapeutic efficacy of Diltiazem can be decreased when used in combination with Meclofenamic acid.
Nifedipine Nifedipine Meclofenamic acid may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Timolol Timolol Meclofenamic acid may decrease the antihypertensive activities of Timolol.
Verapamil Verapamil Meclofenamic acid may decrease the excretion rate of Verapamil which could result in a higher serum level.
Atenolol Atenolol Meclofenamic acid may decrease the antihypertensive activities of Atenolol.
Pindolol Pindolol Meclofenamic acid may decrease the antihypertensive activities of Pindolol.
Cisplatin Injection Cisplatin Injection Meclofenamic acid may decrease the excretion rate of Cisplatin which could result in a higher serum level.
Diflunisal Diflunisal The therapeutic efficacy of Diflunisal can be decreased when used in combination with Meclofenamic acid.
Piroxicam Piroxicam The risk or severity of adverse effects can be increased when Piroxicam is combined with Meclofenamic acid.
Bumetanide Bumetanide The therapeutic efficacy of Bumetanide can be decreased when used in combination with Meclofenamic acid.
Glyburide Glyburide The protein binding of Glyburide can be decreased when combined with Meclofenamic acid.
Glipizide Glipizide The protein binding of Glipizide can be decreased when combined with Meclofenamic acid.
Indapamide Indapamide The therapeutic efficacy of Indapamide can be decreased when used in combination with Meclofenamic acid.
Amoxicillin Amoxicillin Meclofenamic acid may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Meclofenamic acid may decrease the excretion rate of Oxacillin which could result in a higher serum level.
Pentoxifylline Pentoxifylline The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Pentoxifylline.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Meclofenamic acid may decrease the excretion rate of Ceftriaxone which could result in a higher serum level.
Labetalol Labetalol Meclofenamic acid may decrease the antihypertensive activities of Labetalol.
Auranofin Auranofin Meclofenamic acid may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Meclofenamic acid may decrease the excretion rate of Leuprolide which could result in a higher serum level.
Gemfibrozil Gemfibrozil Meclofenamic acid may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz The therapeutic efficacy of Guanabenz can be decreased when used in combination with Meclofenamic acid.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Ketoprofen Ketoprofen The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Ketoprofen.
Cefotetan Injection Cefotetan Injection Meclofenamic acid may decrease the excretion rate of Cefotetan which could result in a higher serum level.
Enalapril Enalapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Enalapril.
Flurbiprofen Flurbiprofen The risk or severity of adverse effects can be increased when Flurbiprofen is combined with Meclofenamic acid.
Amiodarone Amiodarone The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Amiodarone.
Aztreonam Injection Aztreonam Injection Meclofenamic acid may decrease the excretion rate of Aztreonam which could result in a higher serum level.
Buspirone Buspirone Meclofenamic acid may decrease the excretion rate of Buspirone which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Meclofenamic acid may decrease the excretion rate of Ciprofloxacin which could result in a higher serum level.
Mesalamine Mesalamine The therapeutic efficacy of Mesalazine can be decreased when used in combination with Meclofenamic acid.
Diclofenac Diclofenac The risk or severity of adverse effects can be increased when Diclofenac is combined with Meclofenamic acid.
Fluoxetine Fluoxetine The risk or severity of gastrointestinal bleeding can be increased when Fluoxetine is combined with Meclofenamic acid.
Nimodipine Nimodipine The therapeutic efficacy of Nimodipine can be decreased when used in combination with Meclofenamic acid.
Clozapine Clozapine Meclofenamic acid may decrease the excretion rate of Clozapine which could result in a higher serum level.
Estazolam Estazolam Meclofenamic acid may decrease the excretion rate of Estazolam which could result in a higher serum level.
Ofloxacin Ofloxacin Meclofenamic acid may increase the neuroexcitatory activities of Ofloxacin.
Didanosine Didanosine Meclofenamic acid may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Meclofenamic acid may decrease the excretion rate of Pentostatin which could result in a higher serum level.
Benazepril Benazepril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Benazepril.
Etodolac Etodolac The risk or severity of adverse effects can be increased when Etodolac is combined with Meclofenamic acid.
Felodipine Felodipine The therapeutic efficacy of Felodipine can be decreased when used in combination with Meclofenamic acid.
Fosinopril Fosinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Fosinopril.
Nabumetone Nabumetone The risk or severity of adverse effects can be increased when Nabumetone is combined with Meclofenamic acid.
Quinapril Quinapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Quinapril.
Ramipril Ramipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Ramipril.
Amlodipine Amlodipine Meclofenamic acid may decrease the antihypertensive activities of Amlodipine.
Itraconazole Itraconazole The risk or severity of hyperkalemia can be increased when Meclofenamic acid is combined with Itraconazole.
Lisinopril Lisinopril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Lisinopril.
Oxaprozin Oxaprozin The risk or severity of adverse effects can be increased when Meclofenamic acid is combined with Oxaprozin.
Sotalol Sotalol Meclofenamic acid may decrease the antihypertensive activities of Sotalol.
Bisoprolol Bisoprolol Meclofenamic acid may decrease the antihypertensive activities of Bisoprolol.
Doxazosin Doxazosin The therapeutic efficacy of Doxazosin can be decreased when used in combination with Meclofenamic acid.
Terazosin Terazosin The therapeutic efficacy of Terazosin can be decreased when used in combination with Meclofenamic acid.
Isradipine Isradipine The therapeutic efficacy of Isradipine can be decreased when used in combination with Meclofenamic acid.
Venlafaxine Venlafaxine Venlafaxine may increase the antiplatelet activities of Meclofenamic acid.
Stavudine Stavudine The excretion of Stavudine can be decreased when combined with Meclofenamic acid.
Fluvoxamine Fluvoxamine The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Fluvoxamine.
Nefazodone Nefazodone The risk or severity of gastrointestinal bleeding can be increased when Meclofenamic acid is combined with Nefazodone.
Lamotrigine Lamotrigine Meclofenamic acid may decrease the excretion rate of Lamotrigine which could result in a higher serum level.
Losartan Losartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Losartan is combined with Meclofenamic acid.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Tramadol Tramadol Meclofenamic acid may decrease the excretion rate of Tramadol which could result in a higher serum level.
Carboplatin Injection Carboplatin Injection Meclofenamic acid may decrease the excretion rate of Carboplatin which could result in a higher serum level.
Moexipril Moexipril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Moexipril.
Alprostadil Urogenital Alprostadil Urogenital The excretion of Alprostadil can be decreased when combined with Meclofenamic acid.
Ifosfamide Injection Ifosfamide Injection Meclofenamic acid may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Pegaspargase Injection Pegaspargase Injection The therapeutic efficacy of Meclofenamic acid can be increased when used in combination with Pegaspargase.
Nicardipine Nicardipine The therapeutic efficacy of Nicardipine can be decreased when used in combination with Meclofenamic acid.
Bupropion Bupropion Meclofenamic acid may decrease the excretion rate of Bupropion which could result in a higher serum level.
Ticlopidine Ticlopidine The risk or severity of bleeding can be increased when Meclofenamic acid is combined with Ticlopidine.
Metformin Metformin Meclofenamic acid may decrease the excretion rate of Metformin which could result in a higher serum level.
Dalteparin Injection Dalteparin Injection The risk or severity of bleeding and hemorrhage can be increased when Meclofenamic acid is combined with Dalteparin.
Nisoldipine Nisoldipine The therapeutic efficacy of Nisoldipine can be decreased when used in combination with Meclofenamic acid.
Lamivudine Lamivudine Meclofenamic acid may decrease the excretion rate of Lamivudine which could result in a higher serum level.
Acarbose Acarbose Meclofenamic acid may decrease the excretion rate of Acarbose which could result in a higher serum level.
Glimepiride Glimepiride The protein binding of Glimepiride can be decreased when combined with Meclofenamic acid.
Gemcitabine Injection Gemcitabine Injection Meclofenamic acid may decrease the excretion rate of Gemcitabine which could result in a higher serum level.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meclofenamic acid may decrease the excretion rate of Meropenem which could result in a higher serum level.
Clomipramine Clomipramine Meclofenamic acid may decrease the excretion rate of Clomipramine which could result in a higher serum level.
Fosfomycin Fosfomycin Meclofenamic acid may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Meclofenamic acid.
Trandolapril Trandolapril The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Meclofenamic acid is combined with Trandolapril.
Topiramate Topiramate Meclofenamic acid may decrease the excretion rate of Topiramate which could result in a higher serum level.
Valsartan Valsartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Valsartan is combined with Meclofenamic acid.
Pramipexole Pramipexole Meclofenamic acid may decrease the excretion rate of Pramipexole which could result in a higher serum level.
Carvedilol Carvedilol Meclofenamic acid may decrease the antihypertensive activities of Carvedilol.
Nilutamide Nilutamide Meclofenamic acid may decrease the excretion rate of Nilutamide which could result in a higher serum level.
Flutamide Flutamide Meclofenamic acid may decrease the excretion rate of Flutamide which could result in a higher serum level.
Selegiline Selegiline The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Selegiline.
Sertraline Sertraline The risk or severity of bleeding can be increased when Sertraline is combined with Meclofenamic acid.
Propafenone Propafenone Meclofenamic acid may decrease the antihypertensive activities of Propafenone.
Irbesartan Irbesartan The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Irbesartan is combined with Meclofenamic acid.
Tamsulosin Tamsulosin Meclofenamic acid may decrease the excretion rate of Tamsulosin which could result in a higher serum level.
Finasteride Finasteride The risk or severity of hypertension can be increased when Meclofenamic acid is combined with Finasteride.
Quetiapine Quetiapine Meclofenamic acid may decrease the excretion rate of Quetiapine which could result in a higher serum level.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Meclofenamic acid which could result in a higher serum level.
Cetirizine Cetirizine Meclofenamic acid may decrease the excretion rate of Cetirizine which could result in a higher serum level.
Paroxetine Paroxetine The risk or severity of gastrointestinal bleeding can be increased when Paroxetine is combined with Meclofenamic acid.
Tolcapone Tolcapone Meclofenamic acid may decrease the excretion rate of Tolcapone which could result in a higher serum level.
Citalopram Citalopram The risk or severity of gastrointestinal bleeding can be increased when Citalopram is combined with Meclofenamic acid.
Capecitabine Capecitabine Meclofenamic acid may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Abacavir Abacavir Meclofenamic acid may decrease the excretion rate of Abacavir which could result in a higher serum level.
Celecoxib Celecoxib The risk or severity of adverse effects can be increased when Celecoxib is combined with Meclofenamic acid.
Rosiglitazone Rosiglitazone Meclofenamic acid may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.
Tolterodine Tolterodine Meclofenamic acid may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Oseltamivir Oseltamivir Meclofenamic acid may decrease the excretion rate of Oseltamivir which could result in a higher serum level.
Colesevelam Colesevelam Colesevelam can cause a decrease in the absorption of Meclofenamic acid resulting in a reduced serum concentration and potentially a decrease in efficacy.
Balsalazide Balsalazide The therapeutic efficacy of Balsalazide can be decreased when used in combination with Meclofenamic acid.
Nateglinide Nateglinide Meclofenamic acid may decrease the excretion rate of Nateglinide which could result in a higher serum level.
Rabeprazole Rabeprazole Meclofenamic acid may decrease the excretion rate of Rabeprazole which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists